Brief: Vericel Announces FDA Approval Of New State-Of-The-Art Advanced Therapy Manufacturing Facility
04/03/2026 13:04
March 4 (Reuters) - Vericel Corp VCEL.O: VERICEL ANNOUNCES FDA APPROVAL OF NEW STATE-OF-THE-ART ADVANCED THERAPY MANUFACTURING FACILITY VERICEL CORP - TO BEGIN COMMERCIAL MACI PRODUCTION AT NEW FACILITY IN Q2 2026 Source text: ID:nGNX36NXtp Further company coverage: VCEL.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vericel
See all newsMedTech growth concerns likely to overshadow Q3 results, Leerink says
Vericel Corp reports results for the quarter ended June 30 - Earnings Summary
Vericel beats Q2 revenue estimates, boosts annual outlook
Brief: Vericel Q2 EPS USD 0.04
Vericel beats Q1 revenue on MACI, burn care growth, lifts 2026 sales outlook